The hyperactivity of GSK-3β expressed in neurons causes cognitive impairment, tau hyperphosphorylation, increased β-amyloid production, neuronal death, and neuroinflammation leading to the occurrence of depression (18). This evidence concerns the gene MAPT and major depressive disorder.